VRCA
Verrica Pharmaceuticals Inc
4.50$
-5.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 1.9% | 3.9% | 8.0% | 14.6% | 36.2% | 9.7% | |
| – | – | – | – | -1.9% | 96.1% | 92.0% | 85.4% | 63.8% | 90.3% | |
| – | – | – | – | 130.6% | 132.7% | 135.1% | 396.1% | 156.5% | 24.9% | |
| – | – | – | – | 204.2% | 224.8% | 192.7% | 923.1% | 766.8% | 99.0% | |
| – | – | – | – | 332.9% | 353.6% | 327.8% | 1,368.8% | 935.0% | 123.9% | |
| – | – | – | – | -334.8% | -257.6% | -235.8% | -1,283.4% | -871.3% | -33.6% | |
| – | – | – | – | 25.3% | 35.8% | 24.0% | 77.3% | 124.4% | 21.8% | |
| – | – | – | – | -355.8% | -292.3% | -271.1% | -1,307.5% | -1,012.1% | -50.3% | |
| – | – | – | – | 23.4% | 31.9% | 35.3% | 13.0% | – | – | |
| – | – | – | – | -379.1% | -292.3% | -271.1% | -1,307.5% | -1,012.1% | -50.3% | |
| – | – | – | – | -328.6% | -252.6% | -239.1% | -1,213.8% | -871.0% | -26.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.